Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05975619 · ClinicalTrials.gov registry record · NA

A Prospective Imaging Study of the Integrated TrueBeam-HyperSight CBCT System

A NA study of Head and Neck Cancer and Thoracic Cancer, sponsored by Varian, a Siemens Healthineers Company.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05975619 is a NA study of Head and Neck Cancer and Thoracic Cancer that is active but no longer recruiting, run by Varian, a Siemens Healthineers Company. The registered enrollment target is 40 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05975619, a NA study of Head and Neck Cancer and Thoracic Cancer, is active but no longer recruiting, sponsored by Varian, a Siemens Healthineers Company.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Cone beam computed tomography (CBCT) images are routinely used in radiation treatment delivery workflows to align patients with the treatment beam. Conventional CBCT image quality is sufficient for this task but not good enough for other radiotherapy-related tasks, such as contouring anatomical structures and calculating radiation dose distributions. HyperSight is a new CBCT imaging system manufactured by Varian Medical Systems. The purpose of this study is to evaluate the integration of the HyperSight imaging system with Varian's TrueBeam radiotherapy system, a linear accelerator with a C-arm gantry that rotates about the patient to delivery radiation to the target malignancy. HyperSight CBCT images will be acquired prospectively from patients who are receiving radiation treatment. The HyperSight/TrueBeam system will be used for imaging only; patients receive their radiation treatment on cleared devices and no aspect of their treatment is affected by participation in the study. HyperSight images collected during the study will be evaluated for quality and utility and compared to conventional CBCT images as well as fan beam CT images used for treatment planning.

Conditions Studied

Head and Neck Cancer Thoracic Cancer Abdominal Cancer Pelvic Cancer

Interventions

  • DEVICE HyperSight imaging

Study Locations (1)

Ohio

  • University Hospitals Cleveland Medical Center - Cleveland

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-08-29
Est. Completion 2026-04
Phase NA

Sponsor

Varian, a Siemens Healthineers Company

16 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05975619

The ClinicalTrials.gov registry entry for NCT05975619 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (85% lower). The listed sponsor is Varian, a Siemens Healthineers Company, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Head and Neck Cancer appearing as the primary indexed condition, and to 1 intervention - of which HyperSight imaging is the first listed.

NCT05975619 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05975619 about?

NCT05975619 is a clinical study titled "A Prospective Imaging Study of the Integrated TrueBeam-HyperSight CBCT System". Cone beam computed tomography (CBCT) images are routinely used in radiation treatment delivery workflows to align patients with the treatment beam. Conventional CBCT image quality is sufficient for this task but not good enough for other radiotherapy-related tasks, such as contouring anatomical stru...

What is the current status of trial NCT05975619?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-08-29. Estimated completion is 2026-04.

What conditions does trial NCT05975619 study?

This clinical trial studies the following conditions: Head and Neck Cancer, Thoracic Cancer, Abdominal Cancer, Pelvic Cancer.

What interventions are being tested in trial NCT05975619?

The interventions under investigation include: HyperSight imaging (DEVICE).

Who is sponsoring clinical trial NCT05975619?

This trial is sponsored by Varian, a Siemens Healthineers Company, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05975619 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Head and Neck Cancer

All registered trials for this condition

Thoracic Cancer

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.